Yaoxu Chen

457 total citations · 1 hit paper
18 papers, 283 citations indexed

About

Yaoxu Chen is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yaoxu Chen has authored 18 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Yaoxu Chen's work include Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Yaoxu Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Yaoxu Chen collaborates with scholars based in China, Cyprus and United States. Yaoxu Chen's co-authors include Huabin Hu, Yan Huang, Zehua Wu, Zehang Jiang, Yanhong Deng, Jiayu Ling, Xueqian Wu, Chao Wang, Yizhao Luan and Jiaqi Yang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Frontiers in Immunology.

In The Last Decade

Yaoxu Chen

15 papers receiving 283 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

2023 176 citations Jianxia Li, Cheng Wu et al. Cancer Cell profile →

Peers

Yaoxu Chen

ONCOL

IMMUN

PFM

PRM

Xiangbo Meng China

Rebeca Alba Rubío Germany

Zihang Ling China

Ilario Giovanni Rapposelli Italy

Jun‐Ho Lee South Korea

Ting Jiang China

Suiyi Wu China

Bernard S. Buetow United States

Yejing Zhu China

Said Rahim United States

Xiangbo Meng China

Yaoxu Chen

147 ×1.1

ONCOL

184 ×1.5

123 ×1.4

IMMUN

23 ×0.5

PFM

32 ×0.7

PRM

Citations per year, relative to Yaoxu Chen Yaoxu Chen (= 1×) peers Xiangbo Meng

Countries citing papers authored by Yaoxu Chen

Since Specialization

Citations

This map shows the geographic impact of Yaoxu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaoxu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaoxu Chen more than expected).

Fields of papers citing papers by Yaoxu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaoxu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaoxu Chen. The network helps show where Yaoxu Chen may publish in the future.

Co-authorship network of co-authors of Yaoxu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yaoxu Chen. A scholar is included among the top collaborators of Yaoxu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaoxu Chen. Yaoxu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhao, Liying, Hao Liu, Yanfeng Hu, et al.. (2024). Neoadjuvant toripalimab plus CapeOX in patients with localized dMMR/MSI-H gastric or esophagogastric junction adenocarcinoma (GC/EGJC): Results from the cohort C of phase II NICE trial.. Journal of Clinical Oncology. 42(3_suppl). 349–349. 2 indexed citations

Yu, Ling, Jietao Lin, Hanhan Li, et al.. (2023). Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement. Frontiers in Pharmacology. 14. 997760–997760.

Li, Jianxia, Cheng Wu, Huabin Hu, et al.. (2023). Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 41(6). 1152–1169.e7. 176 indexed citations breakdown →

Ye, Ting, Jieying Zhang, Xin-Yi Liu, et al.. (2022). The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma. Frontiers in Immunology. 12. 785526–785526. 7 indexed citations

Huang, Jun, Wan He, Yandong Zhao, et al.. (2022). PD-1 blockade boosted chemo-target therapy in cT4NxM0 pMMR/MSS colorectal cancer.. Journal of Clinical Oncology. 40(16_suppl). e15606–e15606. 2 indexed citations

Xie, Lang, Hongyun Huang, Zheng Zheng, et al.. (2021). MYO1B enhances colorectal cancer metastasis by promoting the F-actin rearrangement and focal adhesion assembly via RhoA/ROCK/FAK signaling. Annals of Translational Medicine. 9(20). 1543–1543. 19 indexed citations

Xiao, Yanni, Mingxing Lei, Wenzhuan Xie, et al.. (2021). Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study. Annals of Translational Medicine. 9(22). 1661–1661. 18 indexed citations

Ye, Ting, Jieying Zhang, Xinyi Liu, et al.. (2021). The predictive value of MAP2K1/2 mutations for efficiency of immunotherapy in melanoma.. Journal of Clinical Oncology. 39(15_suppl). e21587–e21587. 1 indexed citations

Zhao, Fei, et al.. (2021). POLR2A/TPR mutations as potential biomarker for better efficacy of immunoterpy in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 39(15_suppl). e21011–e21011.

10.

Zhao, Yun, Dandan Fan, Xiaochun Huang, et al.. (2021). RECQL5 mutations as a potential efficacious predictor of immunotherapy in melanoma patients.. Journal of Clinical Oncology. 39(15_suppl). e21547–e21547.

11.

Zhang, Ling, Jianping Song, Yi‐Ting Wang, & Yaoxu Chen. (2021). KMT2C as a positive predictor for treatment of immune checkpoint inhibitor and correlation with immune infiltrates in colorectal cancer (CRC).. Journal of Clinical Oncology. 39(15_suppl). 3538–3538. 2 indexed citations

12.

Liu, Jianhua, Qīng Wáng, Yuwei Cong, et al.. (2020). Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report. World Journal of Gastrointestinal Oncology. 12(9). 1065–1072. 1 indexed citations

13.

Zhang, Xingwei, Yonghua Cai, Yujie Hou, et al.. (2020). Correlation between DIDO1 variation and MSI-status in colorectal cancer.. Journal of Clinical Oncology. 38(15_suppl). e16054–e16054. 1 indexed citations

14.

Chen, Yaoxu, Huachun Wang, Yuan Zhang, et al.. (2019). Electrochemically triggered degradation of silicon membranes for smart on-demand transient electronic devices. Nanotechnology. 30(39). 394002–394002. 14 indexed citations

15.

Chen, Yaoxu, et al.. (2019). Isosteviol prevents the development of isoprenaline‑induced myocardial hypertrophy. International Journal of Molecular Medicine. 44(5). 1932–1942. 13 indexed citations

16.

Chen, Yaoxu, et al.. (2017). Attenuation of ischemia/reperfusion-induced inhibition of the rapid component of delayed rectifier potassium current by Isosteviol through scavenging reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859(12). 2447–2453. 11 indexed citations

17.

Chen, Yaoxu, et al.. (2017). Inhibition of rapid delayed rectifier potassium current (IKr) by ischemia/reperfusion and its recovery by vitamin E in ventricular myocytes. Journal of Electrocardiology. 50(4). 437–443. 8 indexed citations

18.

Chen, Yaoxu, et al.. (2016). Isosteviol Sensitizes sarcK_ATP Channels towards Pinacidil and Potentiates Mitochondrial Uncoupling of Diazoxide in Guinea Pig Ventricular Myocytes. Oxidative Medicine and Cellular Longevity. 2016(1). 6362812–6362812. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact